A-LIGN Vulnerability Assessment Service vs Palo Alto Networks Medical Device Security: Side-by-Side Comparison (2026)

Short answer

Mid-market and enterprise teams managing hybrid infrastructure will value A-LIGN Vulnerability Assessment Service for its ability to scan both on-premises and cloud environments in a single workflow without forcing tool consolidation. The service covers authenticated and unauthenticated scans across network and application layers with scheduled continuous monitoring, hitting both ID.RA and DE.CM in NIST CSF 2.0. Skip this if you need a platform that bundles remediation orchestration or threat intelligence; A-LIGN is assessment-focused, leaving remediation execution to your existing ticketing and patching systems. Mid-market and enterprise healthcare organizations need visibility into unmanaged medical devices before they can secure them, and Palo Alto Networks Medical Device Security excels at discovery and risk prioritization where most NAC tools fail. The platform covers asset identification, vulnerability ranking, and virtual patching without requiring device reimaging, which matters in clinical environments where downtime is measured in patient harm. Skip this if your inventory consists entirely of managed endpoints; the value proposition collapses when devices are already enrolled in standard MDM or inventory systems.